Purchase this article with an account.
B. N. D'haene, F. Meire, T. de Ravel, I. Casteels, B. P. Leroy, P. Kestelyn, A. S. Plomp, M. Joosten, A. De Paepe, E. De Baere; FOXC1/PITX2 Mutations and Copy Number Changes in a Belgian-Dutch Cohort of Patients With Axenfeld-Rieger Malformations. Invest. Ophthalmol. Vis. Sci. 2007;48(13):1315. doi: https://doi.org/.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Axenfeld-Rieger (AR) malformations comprise a spectrum of rare autosomal dominant congenital structural malformations of the anterior eye segment. A primary purpose of this study was to determine the prevalence of disease-causing FOXC1/PITX2 mutations and copy number changes in a Belgian-Dutch cohort of patients with AR malformations. A second goal was to evaluate the contribution of three possible candidate genes: FIBULIN-4, P32 and FOXC2.
Genomic DNA was obtained from 36 probands with AR malformations, mostly of Belgian or Dutch origin. The patients were examined for copy number changes of FOXC1/PITX2 with MLPA and screened for subtle FOXC1/PITX2 mutations by sequencing. Array CGH with a tiling BAC array for the FOXC1 region was carried out for the patients with an identified FOXC1 deletion and for all mutation-negative patients. In addition mutation screening of FIBULIN-4, P32 and FOXC2 was performed in the latter group by sequencing.
In the cohort of 36 probands with AR malformations 5 FOXC1 deletions and 1 PITX2 deletion were identified. All FOXC1 deletions were further delineated by array CGH. Furthermore 6 novel FOXC1 mutations were identified including 1 missense, 2 nonsense and 3 frameshift mutations. In addition the 4 novel PITX2 mutations found were 1 missense, 1 frameshift and 2 nonsense mutations. Downstream screening of 14 probands without identifiable FOXC1/PITX2 mutations through array CGH of the FOXC1 region and sequencing of FIBULIN-4, P32 and FOXC2, has so far revealed no disease-causing mutations.
In this mutation study of the FOXC1 and PITX2 genes in a Belgian-Dutch cohort with AR malformations a disease-causing genetic defect was found in 44% of the probands. The majority of these are FOXC1 mutations (69%) and one third PITX2 mutations (31%). Thirty-eight percent of these defects are genomic rearrangements. This study sustains a major role of the FOXC1/PITX2 genes in the molecular pathogenesis of the AR spectrum in the Belgian-Dutch population. Our molecular data will be complemented by phenotypic information in order to establish genotype-phenotype correlations.
This PDF is available to Subscribers Only